As of 2025-04-22, the Fair Value of Novocure Ltd (NVCR) is -7.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.58 USD, the upside of Novocure Ltd is -149.23%.
With the market price of 15.58 USD and our fair value calculation, Novocure Ltd (NVCR) is not a good investment. Investing in Novocure stocks now will result in a potential loss of 149.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 19.80 | -58.40 | -92.50 | -207.04 | -168.63 | -101.35 |
| YoY growth | 375.00% | -394.95% | -58.39% | -123.83% | 18.55% | -36.72% |
| Market Cap (mil) | 1,712.55 |
| P/E | |
| Forward P/E |
| EPS | -1.53 |
| Avg earnings growth rate | -36.72% |
| TTM earnings | -168.63 |